Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-016544

Chief Executive Officer sold 1,125 shares at $55.27 ($62,179)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2024-02-21 Sale 10b5-1 −1,125 $55.27 $62,179 3,106,429 D
Open-market sales · 1,125 sh · avg $55.27 · $62,179
Loading xslF345X05/ownership.xml…